iifl-logo

SBI Healthcare Opportunities Fund G

SBI Healthcare Opportunities Fund G

Fund Name

:  SBI Mutual Fund

Scheme Name

:  SBI Healthcare Opportunities Fund G

AMC

:  SBI Mutual Fund

Type

:  Open

Category

:  Equity - Pharma

Launch Date

:  04-Jun-1999

Fund Manager

:  Tanmaya Desai

Net Assets (Rs. cr)

:  5796.42

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

SBI Healthcare Opportunities Fund G - Nav Details

Nav Date

:  24-Sep-2026

NAV [Rs.]

:  -

Buy/Resale Price [Rs.]

:  -

Sell/Repurchase Price [Rs.]

:  -

Entry Load %

: 

Exit Load %

: 

SBI Healthcare Opportunities Fund G- NAV Chart

SBI Healthcare Opportunities Fund G- Performance(%)

Returns above 1 yr. are annualized

1W
1M
3M
6M
1Y
3Y
5Y
Since INC
Scheme Returns
2.83
2.24
9.03
29.17
21.81
24.05
17.37
15.71
Category Avg
2.91
2
8.3
26.69
18.16
22
14.62
17.2
Category Best
3.78
4.76
11.72
34.99
30.1
25.39
18.62
32.09
Category Worst
2.12
-0.26
2.45
15.34
4.56
17.7
11.57
0.89

SBI Healthcare Opportunities Fund G- Latest Dividends

No Records Found

SBI Healthcare Opportunities Fund G- Investment Details

Min. Investment(Rs.)

:  5000

Increm.Investment(Rs.)

:  1000

In & Out

In

InName Of The CompanyNo Of Shares
--

Out

InName Of The CompanyNo Of Shares
Lupin4,00,000

Fund Holdings

Asset Type
Instrument Name
Industry
Net Assets(%)
No of Shares
Mkt Value(Cr.)
Equity & Equity related Investments
EquitySun Pharma.Inds.Pharmaceuticals & Biotechnology12.333600000714.52
EquityDivi's Lab.Pharmaceuticals & Biotechnology8.17500000473.35
EquityApollo HospitalsHealthcare Services4.91320000284.75
EquityAcutaas ChemicalPharmaceuticals & Biotechnology4.91900000284.45
EquityTorrent Pharma.Pharmaceuticals & Biotechnology4.72540000273.56
EquityCiplaPharmaceuticals & Biotechnology4.671920000270.56
EquityMax HealthcareHealthcare Services4.312400000250.10
EquityLaurus LabsPharmaceuticals & Biotechnology3.961200000229.80
EquityAurobindo PharmaPharmaceuticals & Biotechnology3.901318192226.33
EquityAster DM QualityHealthcare Services3.522700000204.12
EquityGland PharmaPharmaceuticals & Biotechnology2.99600000173.14
EquityAnthem BiosciencPharmaceuticals & Biotechnology2.901880000167.89
EquitySudeep PharmaChemicals & Petrochemicals2.841360000164.51
EquityFortis Health.Healthcare Services2.821800000163.24
EquityBioconPharmaceuticals & Biotechnology2.673750000154.50
EquityJupiter Life LinHealthcare Services2.555000000147.80
EquitySai LifePharmaceuticals & Biotechnology2.521000000145.97
EquityConcord BiotechPharmaceuticals & Biotechnology2.40960000138.82
EquityAether Industri.Chemicals & Petrochemicals2.33799674135.24
EquityPoly MedicureHealthcare Equipment & Supplies1.94640000112.61
EquityGlobal HealthHealthcare Services1.91750000110.97
EquityAjanta PharmaPharmaceuticals & Biotechnology1.86299382107.83
EquityKrishna Institu.Healthcare Services1.731331126100.56
EquityCohance LifePharmaceuticals & Biotechnology1.732200000100.30
EquityMankind PharmaPharmaceuticals & Biotechnology1.6740000096.76
EquityDr Lal PathlabsHealthcare Services1.4744000085.12
EquityHealth.GlobalHealthcare Services1.27100000073.33
EquitySyngene Intl.Healthcare Services1.24180000072.13
EquityNephrocare HealtHealthcare Services1.18100000068.29
EquityRainbow Child.Healthcare Services0.7330000042.44
EquityAbbott IndiaPharmaceuticals & Biotechnology0.35776420.06
EquityGufic BioSciencePharmaceuticals & Biotechnology0.2940000016.65

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Karvy Customer: For activating your account click here.

MY WEALTH AT RETIREMENT

Calculate the worth of your wealth at retirement

Key information

Fund House:
SBI Mutual Fund
Incorporation Date:
07-Feb-1992
Total Assets Managed (Cr.):
12,81,380.67
Trustee/s:
Sandra Martyres, Bharati Rao, Smt. Manju Agarwal, SBI Mutual Fund Trustee C, Richard Mendonca, Mr. Dhruv Prakash
Chairman:
NA
CEO / MD:
Debasish Mishra
CIO:
NA
President:
NA
Director/s:
Dr. Prafulla Agnihotri, Mrs. Madhu Dubhashi, Om Prakash Gahrotra
Compliance Officer/s:
NA
Investor Service Officer/s:
NA
Fund Manager/s:
Tanmaya Desai
Auditors:
NA

OTHER INFORMATION

Registered Office:
9th Floor,Crescenzo, C-39&39, G Block, Bandra kurla complex, Bandra (east), Mumbai-400 051.
Contact Nos:
022-61793000
Fax:
022-67425687
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2026, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099

ISO certification icon
We are ISO/IEC 27001:2022 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.